Larimar Therapeutics Inc (LRMR)
6.40
-0.66
(-9.28%)
USD |
NASDAQ |
Apr 18, 16:00
6.40
0.00 (0.00%)
After-Hours: 20:00
Larimar Therapeutics Price to Book Value: 4.997 for April 18, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 17, 2024 | 5.508 |
| April 16, 2024 | 5.652 |
| April 15, 2024 | 5.699 |
| April 12, 2024 | 5.434 |
| April 11, 2024 | 5.637 |
| April 10, 2024 | 5.340 |
| April 09, 2024 | 5.496 |
| April 08, 2024 | 5.637 |
| April 05, 2024 | 5.808 |
| April 04, 2024 | 5.676 |
| April 03, 2024 | 6.027 |
| April 02, 2024 | 5.746 |
| April 01, 2024 | 5.824 |
| March 28, 2024 | 5.926 |
| March 27, 2024 | 5.672 |
| March 26, 2024 | 5.621 |
| March 25, 2024 | 5.918 |
| March 22, 2024 | 6.316 |
| March 21, 2024 | 6.683 |
| March 20, 2024 | 6.660 |
| March 19, 2024 | 6.706 |
| March 18, 2024 | 6.519 |
| March 15, 2024 | 6.792 |
| March 14, 2024 | 6.788 |
| March 13, 2024 | 7.261 |
| Date | Value |
|---|---|
| March 12, 2024 | 6.847 |
| March 11, 2024 | 6.721 |
| March 08, 2024 | 7.944 |
| March 07, 2024 | 8.505 |
| March 06, 2024 | 8.754 |
| March 05, 2024 | 8.956 |
| March 04, 2024 | 8.894 |
| March 01, 2024 | 8.840 |
| February 29, 2024 | 8.956 |
| February 28, 2024 | 8.956 |
| February 27, 2024 | 9.144 |
| February 26, 2024 | 9.650 |
| February 23, 2024 | 9.439 |
| February 22, 2024 | 9.112 |
| February 21, 2024 | 9.369 |
| February 20, 2024 | 9.393 |
| February 16, 2024 | 9.953 |
| February 15, 2024 | 7.136 |
| February 14, 2024 | 6.426 |
| February 13, 2024 | 4.696 |
| February 12, 2024 | 4.207 |
| February 09, 2024 | 4.170 |
| February 08, 2024 | 3.374 |
| February 07, 2024 | 3.197 |
| February 06, 2024 | 3.331 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5413
Minimum
Aug 05 2022
9.953
Maximum
Feb 16 2024
2.266
Average
1.894
Median
Apr 17 2023
Price to Book Value Benchmarks
| Cogent Biosciences Inc | 3.193 |
| ACADIA Pharmaceuticals Inc | 6.516 |
| PTC Therapeutics Inc | -- |
| Renovaro Inc | 7.547 |
| G1 Therapeutics Inc | 6.144 |
Price to Book Value Related Metrics
| Price | 6.40 |
| Earnings Yield | -13.12% |
| Market Cap | 408.32M |